Delivery Order SPE2DB20D3103-SPE2DB24FP5U8

Award Date 7/17/24
Potential Completion Date 8/7/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,235.16, is for the delivery of the prescription medication Erleada 60 mg tablets. The contract has a firm fixed price pricing type and a completion date of May 19, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,352.49 firm-fixed-price delivery order contract is for the supply of ERLEADA 240 MG TABLET UU 30S, a specialty medication. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,352.49 Firm Fixed Price delivery order covers the supply of ERLEADA 240 MG TABLET medical products. The contract has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $14,704.98 in firm fixed-price delivery orders for the supply of ERLEADA 240 MG Tablets to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,704.98 firm-fixed-price contract is for the delivery of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of June 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $7,106.87 firm-fixed-price contract is for the supply of 4,564,519,776 tablets of the prescription medication Erleada 60 mg. The contract has an ultimate completion date of May 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price contract is for the delivery of ERLEADA 60 MG TABLET UU 120S, a prescription medication. The contract has an ultimate completion date of June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,352.49, is for the delivery of 4,568,076,666 units of the prescription medication Erleada 240 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a $21,320.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Erleada 240 mg tablets. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has a completion date of August 6, 2024 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $7,106.87 firm-fixed-price contract is for the delivery of 120 tablets of the prescription medication Erleada (60 mg) to support DoD and other government healthcare programs. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP5U8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,213.74 firm-fixed-price contract is for the delivery of Erleada 240 mg tablets, a specialty medication. The contract has an ultimate completion date of August 7, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:12 PM